Hey everyone, I’m new to the forum. Since 2020, I have been dealing with non-infective anterior uveitis HLA B27 positive, managed successfully with Prednisolone eye drops. Due to frequent recurrences this past year, my immunologist is considering adalimumab therapy to reduce Prednisolone usage. I’m seeking experiences with adalimumab biosimilars or information on the risks and benefits of this treatment. Thanks in advance.
You must be logged in to post a comment.
 |
|
|
|
We don’t yet have any research data with the biosimilars due to minimal use at this point, but we do know the FDA approval was based on extrapolated data and not head to head studies. Unfortunately, if your insurance mandates a biosimilar you will need to start with the biosimilar and if it fails to work can request switch to Humira brand name.